Avanos Medical (AVNS) Change in Accured Expenses (2013 - 2026)

Avanos Medical has disclosed Change in Accured Expenses across 14 years of filings, most recently posting -$33.7 million for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$33.7 million, down 127.7% year-over-year; the trailing twelve-month figure through Mar 2026 was -$31.8 million (down 2371.43% YoY), and the FY2025 annual result was -$12.9 million, down 13.16% from the prior year.
• Change in Accured Expenses came in at -$33.7 million for Q1 2026 at Avanos Medical, down from $9.5 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $17.4 million in Q3 2023 to a low of -$33.7 million in Q1 2026.
• The 5-year median for Change in Accured Expenses is -$7.2 million (2025), against an average of -$5.5 million.
• Across the five-year window, Change in Accured Expenses plunged 3300.0% in 2023 and soared 276.04% in 2024, its largest moves.
• Avanos Medical's Change in Accured Expenses stood at $11.4 million in 2022, then slumped by 170.18% to -$8.0 million in 2023, then climbed by 3.75% to -$7.7 million in 2024, then soared by 223.38% to $9.5 million in 2025, then slumped by 454.74% to -$33.7 million in 2026.
• The last three Change in Accured Expenses figures came in at -$33.7 million (Q1 2026), $9.5 million (Q4 2025), and -$400000.0 (Q3 2025), per Business Quant data.